BCG Vaccine

  • TRADE NAMES: Mycobax (Sanofi-Aventis); TICE BCG (Organon)
  • INDICATIONS: Immunization against tuberculosis
  • SYNONYM: Bacille Calmette-Guerin
  • CLASS: Vaccine
  • HALF-LIFE: N/A

Abscess 

(2015): Mahmoudi S+, Clin Exp Vaccine Res 4(2), 1952%

(2006): Bolger T+, Arch Dis Child 91(7), 594

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97

(2005): Deeks SL+, Pediatr Infect Dis J 24(6), 538 (with immunodeficiency)

(2005): Schumacher HH+, Plast Reconstr Surg 115(7), 2172

(2003): Prescrire Int 12(68), 220

(2002): Szczuka I, Przegl Epidemiol 56(2), 205

(1994): Taraszkiewicz F+, Przegl Epidemiol 48(4), 505

(1993): Bonnlander H+, Am J Public Health 83(4), 583

(1990): Kulkarni AG+, East Afr Med J 67(12), 922

(1990): Praveen KN+, Pediatr Infect Dis J 9(12), 890

(1989): Murphy PM+, Rev Infect Dis 11(2), 335

(1988): Colebunders RL+, JAMA 259(3), 352

(1988): Simila S+, Tubercle 69(1), 67-9

(1984): Singh G+, Lancet 2(8409), 979

(1981): Di Piramo D+, Riv Med Aeronaut Spaz 46(3-4), 190

Acute febrile neutrophilic dermatosis (Sweet's syndrome) 

(2002): Carpentier O+, Acta Derm Venereol 82(3), 221

(1986): Radeff B+, Acta Derm Venereol 66(4), 357

Allergic granulomatous angiitis / Eosinophilic Granulomatosis with Polyangiitis (EGPA) / Churg-Strauss syndrome (see also anti-neutrophil cytoplasmic antibody (ANCA) vasculitis (angiitis) 

(2006): Chiu YK+, J Am Acad Dermatol 55(2), S1-5 (with monosodium glutamate)

(2006): Seishima M+, Arch Dermatol 142(2), 249

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(2002): Sataynarayana S+, J Assoc Physicians India 50, 788

(2002): Tan HH+, Ann Acad Med Singapore 31(5), 663

(2001): Cohen M+, Diagn Cytopathol 25(2), 134

(2001): Gasior-Chrzan B, Acta Derm Venereol 81(4), 302

(2001): Houcke-Bruge C+, Ann Dermatol Venereol 128(4), 541

(2001): Kakurai M+, Int J Dermatol 40(9), 579

(1997): Emile JF+, J Pathol 181(1), 25-3 [REVIEW]

(1997): Kuniyuki S+, J Am Acad Dermatol 37(2), 303 [REVIEW]

(1997): Pye RJ, Clin Exp Dermatol 22(2), 109

(1990): Torres GM+, AJR Am J Roentgenol 155(1), 195

(1984): Hodsagi M+, Orv Hetil 125(44), 2685

(1980): Martynova MI+, Pediatriia 741(8), 67-7

Anaphylactoid reactions / anaphylaxis (includes anaphylactic shock) 

(2003): Prescrire Int 12(68), 220

(1991): Rudin C+, Lancet 337(8737), 377

(1986): van Assendelft AH+, Tubercle 67(3), 233

(1983): Tshabalala RT, Lancet 1(8325), 653

(1982): Harper JR, Lancet 1(8268), 403

Carcinoma 

(1981): Kendrick MA+, J Natl Cancer Inst 66(3), 431

Dermatitis 

(1998): Dalton SJ+, J R Soc Med 91(3), 133

(1983): Sheikh M, Contact Dermatitis 9(5), 426

Erythema 

(2006): Inoue T+, J Dermatol 33(4), 268

(1994): Lee SM+, J Dermatol 21(2), 106

(1980): Dogliotti M, S Afr Med J 57(9), 332

Erythroderma 

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

Fixed eruption 

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(1988): Kanwar AJ+, Pediatr Dermatol 5(4), 289

Granulomatous reaction 

(2012): Valentini CG+, Mediterr J Hematol Infect Dis 4(1), Epub

Hypersensitivity 

(1998): Grange JM, Commun Dis Public Health 1(2), 84-8 [REVIEW]

(1998): Lowry PW+, J Infect Dis 178(1), 138

Jaundice 

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

Keloid 

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(2004): Sagic L, Med Pregl 57, 41-7

(2003): Boran C+, Pediatr Dermatol 20(5), 460

(1985): Nikolaeva NV, Probl Tuberk BTsZ(7), 58-6

Lichenoid eruption 

(1996): Hwang SM+, Clin Exp Dermatol 21(5), 393

Lupus vulgaris 

(2016): Angoori GR, Pediatr Dermatol 33(5), e274

(2011): Thakur BK+, Int J Dermatol 50(5), 542Pediatric

(2007): Attia E, Eur J Dermatol 17(6), 547

(2005): Bellet JS+, Curr Opin Infect 18(2), 97-1 [REVIEW]

(2004): Senturk N+, Pediatr Dermatol 21(6), 660

(2002): Tan HH+, Ann Acad Med Singapore 31(5), 663

(2001): Handjani F+, Br J Dermatol 144(2), 444

(2001): Kokcam I+, Australas J Dermatol 42(4), 275

(2001): Sasmaz R+, J Dermatol 28(12), 762

(1998): Selimoglu MA+, Turk J Pediatr 40(3), 467

(1997): Hashimoto T, Kekkaku 72(11), 629

(1996): Stewart EJ+, Clin Exp Dermatol 21(3), 232

(1996): Vittori F+, Arch Pediatr 3(5), 457

(1993): Misery L+, Dermatology 186(4), 274

(1991): Marrak H+, Tunis Med 69(11), 651

(1990): Rodrigues A+, Med Cutan Ibero Lat Am 18(4), 224

(1988): Kanwar AJ+, Int J Dermatol 27(7), 525

(1986): Raj B+, Indian J Chest Dis Allied Sci 28(2), 84-7

(1986): Ramirez O+, Med Cutan Ibero Lat Am 14(2), 87-9

(1983): Lassale C+, Arch Fr Pediatr 40(8), 643

(1982): Izumi AK+, Arch Dermatol 118(3), 171

(1982): Ndiaye B+, Dakar Med 27(2), 187

Lymphadenitis 

(2018): Rermruay R+, Vaccine May, Epub ahead of print92%Pediatric

(2017): Bolursaz MR+, Allergol Immunopathol (Madr) 45(4), 35671%

(2016): Hendry AJ+, Commun Dis Intell Q Rep 40(4), e47017%

(2016): Nissen TN+, Vaccine 32(22), 2477 (10 cases)Pediatric

(2015): Mahmoudi S+, Clin Exp Vaccine Res 4(2), 19561%

(2015): Venkataraman A+, Vaccine 33(41), 547065%

(2012): Denadai R+, Indian J Pathol Microbiol 55(2)

(2009): Wu WD+, Zhongguo Ji Hua Mian Yi 15 (6), 491 (suppurative)

(1990): Cannon PF, Mycopathologia 111(2), 75

Lymphadenopathy 

(2016): Hendry AJ+, Commun Dis Intell Q Rep 40(4), e47017%

(2015): Mahmoudi S+, Clin Exp Vaccine Res 4(2), 19520%

(2012): Vera JH+, Int J STD AIDS 23(7), e1

(2006): Bolger T+, Arch Dis Child 91(7), 594

(2005): Nazir Z+, J Ayub Med Coll Abbottabad 17(4), 16-8 (60 cases)

(2005): Teo SS+, Vaccine 23(20), 2676

(2004): Barouni AS+, Braz J Med Biol Res 37(5), 697

(2004): Nieminen T+, Duodecim 120(18), 2247 [REVIEW]

(2004): Sagic L, Med Pregl 57, 41-7

(2004): Vieira AP+, Pediatr Dermatol 21(6), 646

(2003): Prescrire Int 12(68), 220

(2003): Cerda de Palou E+, Ned Tijdschr Geneeskd 147(12), 569

(2003): Salinas Sanz JA+, An Pediatr (Barc) 58(5), 507

(2002): Aribas OK+, Eur J Cardiothorac Surg 21(2), 352

(2002): Goraya JS+, Postgrad Med J 78(920), 327 [REVIEW]

(2002): Sataynarayana S+, J Assoc Physicians India 50, 788

(2002): Singla A+, Pediatr Infect Dis J 21(5), 446

(2002): Szczuka I, Przegl Epidemiol 56(2), 205

(2002): Torres-Rojas JR+, Dermatol Online J 8(2), 6

(2002): Turnbull FM+, Clin Infect Dis 34(4), 447

(2000): Lee TT+, Aust N Z J Surg 70(12), 902

(2000): Raos M+, Lijec Vjesn 122(7-8), 180

(1999): Karnak I+, J Pediatr Surg 34(10), 1534

(1999): Levi DT+, Probl Tuberk T(4), 4-7

(1999): Lin CJ+, J Bone Joint Surg Am 81(9), 1305

(1999): Szczuka I, Pneumonol Alergol Pol 67(5-6), 208<1%

(1998): Grange JM, Commun Dis Public Health 1(2), 84-8 [REVIEW]

(1998): Hofstadler G+, AIDS Patient Care STDS 12(9), 677

(1998): Kuyucu N+, Pediatr Infect Dis J 17(6), 524

(1998): Lowry PW+, J Infect Dis 178(1), 138

(1998): Yan JJ+, J Pathol 184(1), 96-1

(1997): Banac S+, Acta Paediatr 86(8), 899

(1997): Castro-Rodriguez JA+, Int J Tuberc Lung Dis 1(5), 417

(1997): Hashimoto T, Kekkaku 72(11), 629

(1997): Hengster P+, World J Surg 21(5), 520

(1997): Karnak I+, Pediatr Surg Int 12(2-3), 220

(1997): Nishi J+, Pediatr Infect Dis J 16(3), 332

(1996): Fujimoto T+, Int J Oral Maxillofac Surg 25(2), 145

(1996): Jakubikova J+, Int J Pediatr Otorhinolaryngol 37(1), 85-9

(1996): Marcelino F+, Acta Med Port 9(10-1), 397 [REVIEW]

(1996): Mori T+, Tuber Lung Dis 77(3), 269

(1996): Rositto A+, Pediatr Dermatol 13(6), 451

(1995): Kroger L+, J Infect Dis 172(2), 574

(1995): Meijer PJ, Ned Tijdschr Geneeskd 139(52), 2759

(1995): Vitkova E+, Cent Eur J Public Health 3(3), 138

(1995): Withagen MI+, Ned Tijdschr Geneeskd 139(40), 2047

(1994): Hooi LN+, Med J Malaysia 49(4), 327

(1994): Kroger L+, Pediatr Infect Dis J 13(2), 113

(1994): Kumar PV+, Acta Cytol 38(2), 165

(1994): Olsztajn N+, Arch Pediatr 1(1), 101

(1994): Taraszkiewicz F+, Przegl Epidemiol 48(4), 505

(1994): Walter S+, Klin Padiatr 206(6), 433

(1993): Arya SC, Lancet 341(8858), 1482

(1993): Bonnlander H+, Am J Public Health 83(4), 583

(1993): Gocmen A+, Turk J Pediatr 35(3), 215

(1993): Romanus V+, Acta Paediatr 82(12), 1043

(1992): Hengster P+, Arch Dis Child 67(7), 952

(1992): Hoppe JE+, Infection 20(2), 94-6

(1992): Krepela V+, Cesk Pediatr 47(3), 134

(1991): Allerberger F, Am Rev Respir Dis 144(2), 469

(1991): Baki A+, Infection 19(6), 414

(1991): Caglayan S+, Acta Paediatr Jpn 33(6), 699 (50 cases)

(1991): Hengster P+, Lancet 337(8750), 1168

(1991): Spiess H, Offentl Gesundheitswes 53(8-9), 631

(1991): Stogmann W, Wien Med Wochenschr 141(12), 265 [REVIEW]

(1991): Teulieres L+, Vaccine 9(7), 521

(1990): Aggarwal NP+, Indian J Pediatr 57(4), 585

(1990): Gaitnietse Ria+, Probl Tuberk 227(9), 32-4

(1990): Heydolph F+, Z Erkr Atmungsorgane 175(2), 90-4

(1990): Newfield L+, Harefuah - Harefuah 119(7-8), 199

(1990): Praveen KN+, Pediatr Infect Dis J 9(12), 890

(1989): Burdeny DA+, Can Assoc Radiol J 40(2), 92-3

(1988): Ray CS+, Cent Afr J Med 34(12), 281

(1987): Caglayan S+, Am J Dis Child 141(11), 1213

(1986): Hanna JN, Med J Aust 145(11-1), 662

(1986): Helmick CG+, West Indian Med J 35(1), 12-7

(1986): Ivanenko OM, Probl Tuberk diag(4), 27-3

(1986): Loos T, Dev Biol Stand 58, 351

(1986): Nyerges G+, Orv Hetil 127(43), 2607

(1986): Quast U+, Dev Biol Stand 58, 321

(1986): Stephan U+, Klin Padiatr 198(4), 295<1%

(1985): Abdullah MA+, Ann Trop Paediatr 5(2), 77-8

(1985): Kasatkin VM, Probl Tuberk (7), 71-2

(1985): Victoria MS+, Pediatr Infect Dis 4(3), 295

(1984): Easton PA+, Tubercle 65(3), 205

(1984): Katzir Z+, Eur J Pediatr 141(3), 165

(1984): Kobayashi Y+, Clin Pediatr (Phila) 23(10), 586

(1983): Close GG+, Arch Dis Child 58(11), 939

(1983): de Souza+, Tubercle 64(1), 23-7

(1982): Tam PK+, Arch Dis Child 57(12), 952

(1980): Bhandari B+, Indian J Pediatr 47(388), 367

(1980): Mackay A+, Lancet 2(8208), 1332

Necrosis / skin necrosis 

(2012): Gyldenlove M+, Hum Vaccin Immunother 8(4), 423

Papular lesions 

(2006): Muto J+, Clin Exp Dermatol 31(4), 611 [REVIEW]

(1998): Karte K+, Pediatr Dermatol 15(1), 73-4

(1996): Rositto A+, Pediatr Dermatol 13(6), 451

(1987): Figueiredo A+, Int J Dermatol 26(5), 291

(1984): Lorette G+, Ann Dermatol Venereol 111(5), 493

(1982): Lubbe D, Dermatol Monatsschr 168(3), 186

Pityriasis rosea 

(1989): Kaplan B+, Isr J Med Sci 25(10), 570

Psoriasis 

(2004): Koca R+, J Trop Pediatr 50(3), 178

Sarcoidosis / sarcoid-like reaction (cutaneous sarcoidosis) 

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(2003): Osborne GE+, J Am Acad Dermatol 48(5), S99

(1989): Greally JF+, Sarcoidosis 6(2), 156

(1988): McLelland J+, Arch Dermatol 124(4), 496

Scar 

(2005): Roth A+, Vaccine 23(30), 3991

(2005): Zhivotovskii BG+, Probl Tuberk Bolezn Legk L(1), 32-3

(2004): Gross S+, Clin Infect Dis 38(10), 1495

(1999): Guerin N+, Vaccine 17(2), 105

(1993): Fang JW+, Child Care Health Dev 19(1), 37-4

(1993): Kwamanga D+, East Afr Med J 70(9), 568

(1990): Sivarajah N+, Ceylon Med J 35(2), 75-786%

(1982): Sanders R+, Br Med J (Clin Res Ed) 285(6356), 1679

Scrofuloderma 

(2005): Atasoy M+, Pediatr Dermatol 22(2), 179

(2005): Kumaran MS+, Lepr Rev 76(2), 170

(2003): Corrales IF+, Biomedica 23(2), 202

(2002): Tan H+, Pediatr Dermatol 19(4), 323

(1999): Park YM+, J Am Acad Dermatol 41(2), 262

Squamous cell carcinoma 

(2011): Thakur BK+, Int J Dermatol 50(5), 542Pediatric

Telangiectasia 

(1994): Lee SM+, J Dermatol 21(2), 106

Tumors 

(1993): Wolff M+, Monatsschr Kinderheilkd 141(5), 409

Ulcerations 

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(2004): Cuchet E+, Ann Dermatol Venereol 131(12), 1077

(2003): Prescrire Int 12(68), 220

(2002): Fritz TM+, Hautarzt - Der 53(12), 816

(2002): Szczuka I, Przegl Epidemiol 56(2), 205

(1983): de Souza+, Tubercle 64(1), 23-7

Urticaria / hives 

(1993): Misery L+, Ann Dermatol Venereol 120(3), 233 [REVIEW]

Mucocutaneous lymph node syndrome 

(Kawaski syndrom)

(2005): Bellet JS+, Curr Opin Infect Dis 18(2), 97-1 [REVIEW]

(1996): Edelman K+, Duodecim 112(8), 698

Fever (pyrexia) (includes hyperpyrexia) 

(2014): Linden-Castro E+, Urology 84(2), e3 (passim)

(2012): Raheem OA+, Actas Urol Esp (Spanish) 36(8), 46158%

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

(2004): Mugiya S+, Hinyokika Kiyo 50 (7), 4699%

(1998): N Engl J Med 339 (12), 831

(1992): Lamm DL+, J Urol 147 (3), 596

Neurotoxicity 

(1999): Wilmshurst JM+, Eur J Paediatr Neurol 3(6), 277

(1982): Katznelson D+, Postgrad Med J 58(682), 496

Hepatitis 

(2012): Desmet M+, Acta Clin Belg 67(5), 367

(1998): N Engl J Med 339 (12), 831

(1992): Lamm DL+, J Urol 147 (3), 596

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI) 

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

(1991): Simma B+, Eur J Pediatr 150(6), 423

Vomiting  

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

Balanitis (glans penile inflammation) 

(2013): Garcia Baldovi M+, Actas Dermosifiliogr 104(3), 251

(2008): Michelet N+, Ann Dermatol Venereol (French) 135(6-7), 479 (2 cases)

(2006): Yusuke H+, Int J Urol 13(10), 1361

Bladder disorder 

(2012): Nagayama T+, Gan To Kagaku Ryoho 39(11), 1681

(2004): Mugiya S+, Hinyokika Kiyo 50 (7), 46949% (irritability)

Cystitis 

(2014): Linden-Castro E+, Urology 84(2), e3 (passim)

Epididymitis 

(2012): Demers V+, J Radiol Case Rep 6(11), 16

Hematuria 

(2014): Linden-Castro E+, Urology 84(2), e3 (passim)

(2004): Mugiya S+, Hinyokika Kiyo 50 (7), 46919% (gross)

Prostatitis 

(2012): Humphrey PA, J Urol 188(3), 961

Pyuria 

(2004): Mugiya S+, Hinyokika Kiyo 50 (7), 46947%

Pancytopenia (includes bicytopenia) 

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

Sepsis 

(2001): Andres E+, QJM 94 (12)

(1998): N Engl J Med 339 (12), 831

(1992): Lamm DL+, J Urol 147 (3), 596 (fatal)Fatal

Injection-site abscess 

(2016): Hendry AJ+, Commun Dis Intell Q Rep 40(4), e47031%

(2002): Turnbull FM+, Clin Infect Dis 34(4), 447

(1998): Grange JM, Commun Dis Public Health 1(2), 84-8 [REVIEW]

Injection-site edema 

(2009): Wu WD+, Zhongguo Ji Hua Mian Yi 15 (6), 491

Injection-site erythema 

(2009): Wu WD+, Zhongguo Ji Hua Mian Yi 15 (6), 491

Injection-site granuloma 

(1966): Falk AB+, Arch Dermatol 94(6), 806

Injection-site induration 

(2009): Wu WD+, Zhongguo Ji Hua Mian Yi 15 (6), 491

Injection-site reaction 

(2017): Bolursaz MR+, Allergol Immunopathol (Madr) 45(4), 356 [REVIEW]71%

(2016): Hendry AJ+, Commun Dis Intell Q Rep 40(4), e47027%

(2015): Venkataraman A+, Vaccine 33(4), 547030%

Injection-site ulceration 

(2018): Richardus R+, Front Immunol 9, 629

(2012): Gyldenlove M+, Hum Vaccin Immunother 8(4), 423

(1997): Pankowska A+, Pneumonol Alergol Pol 65(11-1), 761

(1991): Spiess H, Offentl Gesundheitswes 53(8-9), 631

Arthralgia 

(2012): Kwan K+, Int J Rheum Dis 15(4), e73

(2012): Kwan K+, Int J Rheum Dis 15(4), e73

(2006): Ayadi K+, Rev Chir Orthop Reparatrice Appar Mot 92(1), 60-3

(1999): Nesher G, J Rheumatol 26(7), 1638

(1999): Schwartzenberg JM+, J Rheumatol 26(4), 933

(1998): Kodali VR+, J Intern Med 244(2), 183

(1995): Missioux D+, J Rheumatol 22(10), 2010

Asthenia / fatigue 

(2014): Linden-Castro E+, Urology 84(2), e3 (passim)

(2014): Venn RM+, BMJ Case Rep May, Epub

(2009): Korac M+, Med Pregl 62 (11-12), 592 (following intravesical therapy)

(1992): Lamm DL+, J Urol 147 (3), 596

Bone or joint pain 

(2012): Raheem OA+, Actas Urol Esp (Spanish) 36(8), 46168%

Osteomyelitis 

(2018): Rermruay R+, Vaccine May, Epub ahead of print5%Pediatric

(2017): Al-Azri MS+, Sultan Qaboos Univ Med J 17(3), e358Pediatric

(2006): Khotaei GT+, J Microbiol Immunol Infect 39(2), 169

(2006): Segal S+, Arch Dis Child 91(3), 244

(2005): Deeks SL+, Pediatr Infect Dis J 24(6), 538 (with immunodeficiency)

(2004): Kovalenko KN+, Probl Tuberk Bolezn Legk 151(1), 21-4

(2003): Prescrire Int 12(68), 220

(2003): Blaha J+, Z Orthop Ihre Grenzgeb 141(5), 595

(2003): Corrales IF+, Biomedica 23(2), 202

(2002): Aribas OK+, Eur J Cardiothorac Surg 21(2), 352

(2001): Cohen M+, Diagn Cytopathol 25(2), 134

(1990): Friebel D+, Kinderarztl Prax 58(4), 199

(1990): Moreno L+, Eur J Pediatr 149(9), 668

(1990): Muller-Miny H+, Radiologe 30(7), 328 [REVIEW]

(1990): Schulze W, Pneumologie 44, 484

(1988): Marik I+, J Pediatr Orthop 8(3), 333

(1988): Szabo L+, Orv Hetil 129(41), 2203

(1987): Arias FG+, Pediatr Radiol 17(2), 166

(1987): Hanimann B+, Schweiz Med Wochenschr 117(6), 193

(1986): Aftimos S+, N Z Med J 99(800), 271

(1986): Beyer WF+, Z Orthop Ihre 124(6), 688

(1986): Blaha J+, Acta Chir Orthop Traumatol Cech 53(2), 164

(1986): Kolandaivelu G+, J Indian Med Assoc 84(6), 184

(1985): Krepela K+, Cesk Pediatr 40(5), 263

(1984): Al-Arabi KM+, Tubercle 65(4), 305

(1984): Hajkova H+, Rozhl Chir 63(11), 754

(1984): Marik I+, Acta Chir Orthop Traumatol Cech 51(6), 495

(1984): Peltola H+, Arch Dis Child 59(2), 157

(1983): Moell C+, Acta Paediatr Scand 72(1), 153

(1983): Sandstrom S, Pediatr Radiol 13(4), 239

(1982): Bottiger M+, Acta Paediatr Scand 71(3), 471

(1982): Kamran D+, Monatsschr Kinderheilkd 130(12), 899

(1982): Schopfer K+, Helv Paediatr Acta 37(1), 73-8

(1981): Berges O+, Skeletal Radiol 7(1), 75-7

(1981): Weh L+, Z Orthop Ihre Grenzgeb 119(3), 297

Reiter's syndrome (reactive arthritis) 

(2021): Abdelghani KB+, Curr Rheumatol Rep 23(6), 39 [REVIEW]

(2017): Ikeuchi R+, Hinyokika Kiyo (Japanese) 63(8), 329-332

(2015): Koike M+, Nihon Hinyokika Gakkai Zasshi (Japanese) 106(4), 238-42

Iritis 

(1995): Missioux D+, J Rheumatol 22(10), 2010

Optic neuritis 

(2005): Hegde V+, Acta Paediatr 94(5), 635

(1991): Yen MY+, J Clin Neuroophthalmol 11(4), 246

Uveitis / anterior uveitis / posterior uveitis / panuveitis 

(2015): Cordero-Coma M+, Expert Opin Drug Saf 14(1), 111

(2012): Loukil I+, Bull Soc Belge Ophtalmol (French) (320), 23

(2005): Hegde V+, Acta Paediatr 94(5), 635

(1999): Chevrel G+, J Rheumatol 26(4), 1011

Tuberculosis 

(2011): Sharma VK+, Indian J Dermatol Venereol Leprol 77(1), 47 (penis)

Adverse effects / adverse reactions 

(2018): Sellami K+, Indian J Dermatol 63(1), 62

(2016): Mostaan S+, Adv Biomed Res 5, 99 [REVIEW]

(2015): Mayet A+, Public Health 129(6), 763

(2012): Krysztopa-Grzybowska K+, Przegl Epidemiol 66(3), 465

Cancer 

(2005): Gunlusoy B+, Urol Int 75 (2), 107 (tumor recurrence)

(2003): Shahin O+, J Urol 169 (1), 96 (tumor recurrence)

(2000): Brake M+, Urology 55 (5), 673 (tumor recurrence)

Death 

(2006): Hesseling AC+, Clin Infect Dis 42(4), 548 (with immunodeficiency)

(2005): Deeks SL+, Pediatr Infect Dis J 24(6), 538 (with immunodeficiency)

(2004): Sagic L, Med Pregl 57, 41-7

(2000): Doffinger R+, J Infect Dis 181(1), 379

(2000): Peyriere H+, Ann Pharmacother 34(11), 1279

(1997): Banac S+, Acta Paediatr 86(8), 899

(1997): Emile JF+, J Pathol 181(1), 25-3 [REVIEW]

(1997): Hashimoto T, Kekkaku 72(11), 629

(1996): Casanova JL+, Pediatrics 98(4), 774

(1996): Jouanguy E+, N Engl J Med 335(26), 1956

(1992): Lamm DL+, J Urol 147(3), 596

(1986): Fasth A, Lakartidningen 83(11), 969

(1982): Trevenen CL+, Can Med Assoc J 127(6), 502

(1980): Perelman R+, Sem Hop 56(9-10), 480

Infection 

(2017): Liaw F+, Clin Case Rep 5(10), 1569

(2014): Linden-Castro E+, Urology 84(2), e3

(2004): Zwolska Z+, Pneumonol Alergol Pol 72(11-1), 505

Multiorgan failure 

(2012): Desmet M+, Acta Clin Belg 67(5), 367

Side effects 

(2012): Librenjak D+, Acta Clin Croat 51(2), 20127%

Systemic reactions 

(2010): Nazir T+, Br J Hosp Med (Lond) 71(8), 472

(2000): Peyriere H+, Ann Pharmacother 34(11), 1279 (fatal)Fatal



Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top